EUVIMEDEUVIMED entdecken
Crossref

Tourniquet-Test – An additional diagnostic tool in diagnosis of hereditary haemorrhagic telangiectasia?

Marie Carolin Schleupner, Helena Boehm, Lukas Boosfeld, Julia Garvert, Christina Kaiser, Antonia Lakomek, Nadia Sadok, Felicia Toppe, Noemi Voß, Stephan Lang, Urban Geisthoff, Freya Dröge

Laryngo-Rhino-Otologie · 01.05.2024 · 103 (S 02 S 02) · S319

DOI: 10.1055/s-0044-1785078 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Laryngo-Rhino-Otologie, erschienen am 01.05.2024. Verfasst von Marie Carolin Schleupner und 11 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The Tourniquet test is used as a diagnostic procedure for increased bleeding tendency due to e.g. thrombocytopathies and vascular diseases and is also mentioned in textbooks for hereditary haemorrhagic telangiectasia (HHT). To our knowledge, there is a lack of evidence for the latter and this was the aim of our investigations. Material and methods We performed the Tourniquet test in patients with a confirmed diagnosis of HHT (≥3 Curaçao criteria or positive molecular genetics). If the test result was positive (≥10 petechiae), extended coagulation diagnostics were performed wherever possible.

Results

A total of 92 patients with HHT were included (62% women), of whom 44 patients (48%) tested positive. Neither the overall test result nor the number of petechiae showed statistically significant correlations with individual patient characteristics including severity of the disease (Epistaxis Severity Score, Toronto Severity Score), use of anticoagulant or antiplatelet medication, or laboratory parameters including platelet count. Coagulation could be further analysed in 23 patients who tested positive and only two patients were found to have slightly reduced factor activities (IX and X).

Discussion

The test was positive in 48% of those affected, which is relatively high compared to other areas of application. This indicates an increased vulnerability of the vessels to pressure in HHT, which to our knowledge has not yet been described. Publication History Article published online: 19 April 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

Zitieren

APA

Schleupner, M. C., Boehm, H., Boosfeld, L., Garvert, J., Kaiser, C., Lakomek, A., Sadok, N., Toppe, F., Voß, N., Lang, S., Geisthoff, U., & Dröge, F. (2024). Tourniquet-Test – An additional diagnostic tool in diagnosis of hereditary haemorrhagic telangiectasia?. Laryngo-Rhino-Otologie, 103(S 02 S 02), S319. https://doi.org/10.1055/s-0044-1785078

Vancouver

Schleupner MC, Boehm H, Boosfeld L, Garvert J, Kaiser C, Lakomek A, et al. Tourniquet-Test – An additional diagnostic tool in diagnosis of hereditary haemorrhagic telangiectasia?. Laryngo-Rhino-Otologie. 2024;103(S 02 S 02):S319. doi:10.1055/s-0044-1785078

BibTeX
@article{Schleupner2024,
  author = {Schleupner, Marie Carolin and Boehm, Helena and Boosfeld, Lukas and Garvert, Julia and Kaiser, Christina and Lakomek, Antonia and Sadok, Nadia and Toppe, Felicia and Voß, Noemi and Lang, Stephan and Geisthoff, Urban and Dröge, Freya},
  title = {Tourniquet-Test – An additional diagnostic tool in diagnosis of hereditary haemorrhagic telangiectasia?},
  journal = {Laryngo-Rhino-Otologie},
  year = {2024},
  volume = {103},
  number = {S 02 S 02},
  pages = {S319},
  doi = {10.1055/s-0044-1785078}
}
Kostenlos starten →